Benjamin Addy, PA
Physician Assistant · West Columbia, SCNPI 1831520782
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $285,265 of the $377,147 with a category attached, or 75.6%. 35 manufacturers reported payments, led by Galderma Laboratories, L.p. at 26.1% of the total. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,674 payments — averaging $225.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$98K
- UCB, Inc.$84K
- Johnson & Johnson$67K
- Dermavant Sciences, Inc.$51K
- Janssen Scientific Affairs, LLC$33K
- Organon$19K
- plus $25K from 29 others
What the payments were for
- Consulting fees$6,9172%
- Speaking & faculty fees$285,26576%
- Travel & lodging$33,8639%
- Food & beverage$50,52313%
- Education$5800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 210 | $98,454 |
| UCB, Inc. | 148 | $83,930 |
| Johnson & Johnson | 138 | $66,730 |
| Dermavant Sciences, Inc. | 117 | $51,135 |
| Janssen Scientific Affairs, LLC | 37 | $32,920 |
| Organon | 53 | $19,318 |
| AbbVie | 191 | $5,724 |
| LEO Pharma Inc. | 57 | $2,281 |
| Novartis | 112 | $2,276 |
| Regeneron Healthcare Solutions, Inc. | 90 | $2,193 |
| Incyte Corporation | 50 | $2,033 |
| Sun Pharmaceutical Industries Inc. | 88 | $1,795 |
| Amgen | 61 | $1,325 |
| Sanofi | 53 | $1,123 |
| E.r. Squibb & Sons, L.L.C. | 43 | $938 |
| Pfizer | 49 | $928 |
| Lilly USA, LLC | 49 | $872 |
| Arcutis Biotherapeutics, Inc. | 36 | $750 |
| Journey Medical Corporation | 1 | $750 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 23 | $391 |
| EPI Health, LLC | 22 | $363 |
| VYNE Pharmaceuticals Inc. | 7 | $214 |
| Boehringer Ingelheim | 9 | $203 |
| Mayne Pharma Commercial LLC | 14 | $187 |
| Verrica Pharmaceuticals Inc. | 4 | $85 |
| Mylan Institutional Inc. | 2 | $40 |
| Smith+Nephew | 2 | $34 |
| Kerecis Limited | 1 | $29 |
| Fresenius Kabi USA, LLC | 1 | $26 |
| Biocon Biologics Inc | 1 | $24 |
| Botanix SB Inc | 1 | $17 |
| Kyowa Kirin, Inc. | 1 | $16 |
| Biofrontera Inc. | 1 | $16 |
| Scynexis, Inc. | 1 | $14 |
| Access Pro Medical, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$377,147 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 115 | $485,945 |
| Skyrizi PenRisankizumab-Rzaa | 18 | $380,501 |
| OtezlaApremilast | 77 | $378,011 |
| Humira(Cf) PenAdalimumab | 20 | $338,101 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 27 | $216,999 |
| Cosentyx Unoready PenSecukinumab | 18 | $195,894 |
| TremfyaGuselkumab | 13 | $175,489 |
| RinvoqUpadacitinib | 19 | $155,959 |
| VtamaTapinarof | 15 | $20,934 |
| Triamcinolone Acetonide | 291 | $10,797 |
| Tacrolimus | 84 | $10,395 |
| Clobetasol Propionate | 187 | $6,441 |
| Fluorouracil | 68 | $4,167 |
| Ketoconazole | 203 | $3,650 |
| Metronidazole | 79 | $3,601 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $1,325 | $378,01177 claims |
| Johnson & JohnsonTremfya | $66,730 | $175,48913 claims |
| AbbVieRinvoq | $5,724 | $155,95919 claims |
| Dermavant Sciences, Inc.Vtama | $51,135 | $20,93415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in West Columbia
- Vicki RobertsWest Columbia$77K
- Andre KennedyWest Columbia$9K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.